The generic name of Human Interleukin 2 for Injection is Recombinant Human Interleukin-2 for Injection, which has the efficacy of anti-virus, anti-tumor, and enhancement of body immune function.
1. It has certain therapeutic effects on certain viral, mycobacterial diseases and intracellular parasitic bacterial infectious diseases, such as hepatitis B, leprosy, pulmonary tuberculosis and Candida albicans infection.
2. It is used in the treatment of malignant tumors such as renal cell carcinoma, melanoma, breast cancer, bladder cancer, etc. It is used in the control of carcinomatous pleural and abdominal fluid, and can also be used in the culture of lymphokine-activated killer cells, which can enhance the immune function of patient’s organism.
3. It is used in the treatment of congenital or acquired immunodeficiency, to improve the patient’s cellular immune function and anti-infection ability; the treatment of various autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, desiccation syndrome and so on.
4. Recombinant human interleukin-2 for injection may cause fever, chills, nausea, vomiting and other adverse reactions, allergic to the components of the product, severe heart disease, severe cardiac and renal insufficiency, sustained ventricular tachycardia, cardiac tamponade, organ transplantation and other patients are contraindicated.
5. Use with caution in pregnant and lactating women.
This product must be used with caution under the guidance of experienced specialists.